Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program "Treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in Poland
| Autor: | Owczarek, Witold1, Walecka, Irena2 irena.walecka@cskmswia.pl, Nowakowska, Agnieszka1, Ciechanowicz, Piotr2, Reich, Adam3, Lesiak, Aleksandra4, Borkowska, Ewa5, Śliwczyński, Andrzej6, Narbutt, Joanna4 |
|---|---|
| Zdroj: | Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii. 2022, Vol. 39 Issue 4, p723-728. 6p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|